BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 22981753)

  • 1. Polymer therapeutics-prospects for 21st century: the end of the beginning.
    Duncan R; Vicent MJ
    Adv Drug Deliv Rev; 2013 Jan; 65(1):60-70. PubMed ID: 22981753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric carriers: preclinical safety and the regulatory implications for design and development of polymer therapeutics.
    Gaspar R; Duncan R
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1220-31. PubMed ID: 19682513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymer therapeutics: Top 10 selling pharmaceuticals - what next?
    Duncan R
    J Control Release; 2014 Sep; 190():371-80. PubMed ID: 24818766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer therapeutics: concepts and applications.
    Haag R; Kratz F
    Angew Chem Int Ed Engl; 2006 Feb; 45(8):1198-215. PubMed ID: 16444775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated polymers for medicine: from conjugation to self-assembled systems.
    Joralemon MJ; McRae S; Emrick T
    Chem Commun (Camb); 2010 Mar; 46(9):1377-93. PubMed ID: 20162127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dawning era of polymer therapeutics.
    Duncan R
    Nat Rev Drug Discov; 2003 May; 2(5):347-60. PubMed ID: 12750738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing polymer conjugates as lysosomotropic nanomedicines.
    Duncan R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymer-drug conjugates: origins, progress to date and future directions.
    Kopeček J
    Adv Drug Deliv Rev; 2013 Jan; 65(1):49-59. PubMed ID: 23123294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable amphiphilic polymer-drug conjugate micelles.
    Hu X; Jing X
    Expert Opin Drug Deliv; 2009 Oct; 6(10):1079-90. PubMed ID: 19645633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer-drug conjugates: present state of play and future perspectives.
    Pang X; Du HL; Zhang HQ; Zhai YJ; Zhai GX
    Drug Discov Today; 2013 Dec; 18(23-24):1316-22. PubMed ID: 24055841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymer-drug conjugate therapeutics: advances, insights and prospects.
    Ekladious I; Colson YL; Grinstaff MW
    Nat Rev Drug Discov; 2019 Apr; 18(4):273-294. PubMed ID: 30542076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiomers: promising platform for macromolecular drug delivery.
    Laffleur F; Bernkop-Schnürch A
    Future Med Chem; 2012 Nov; 4(17):2205-16. PubMed ID: 23190108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiomers for oral delivery of hydrophilic macromolecular drugs.
    Bernkop-Schnürch A; Hoffer MH; Kafedjiiski K
    Expert Opin Drug Deliv; 2004 Nov; 1(1):87-98. PubMed ID: 16296722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer--drug conjugates as nano-sized medicines.
    Canal F; Sanchis J; Vicent MJ
    Curr Opin Biotechnol; 2011 Dec; 22(6):894-900. PubMed ID: 21724381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges.
    Duncan R; Richardson SC
    Mol Pharm; 2012 Sep; 9(9):2380-402. PubMed ID: 22844998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymer therapeutics--polymers as drugs, drug and protein conjugates and gene delivery systems: past, present and future opportunities.
    Duncan R; Ringsdorf H; Satchi-Fainaro R
    J Drug Target; 2006 Jul; 14(6):337-41. PubMed ID: 17092834
    [No Abstract]   [Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines.
    Greco F; Vicent MJ
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1203-13. PubMed ID: 19699247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrotropic polymer micelles as versatile vehicles for delivery of poorly water-soluble drugs.
    Kim JY; Kim S; Pinal R; Park K
    J Control Release; 2011 May; 152(1):13-20. PubMed ID: 21352878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of daunomycin and oxaliplatin by biodegradable polymers for safer and more efficacious combination therapy.
    Xiao H; Li W; Qi R; Yan L; Wang R; Liu S; Zheng Y; Xie Z; Huang Y; Jing X
    J Control Release; 2012 Nov; 163(3):304-14. PubMed ID: 22698937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.